Global Cord Blood
CORBF
$1.25
Share price
0.00%
Change (1 day)
-58.19%
Change (1 year)
Categories
EPS for Global Cord Blood (CORBF)
EPS in 2022 (TTM): $0.64
According to Global Cord Blood's latest financial reports the company's current EPS (TTM) is $0.64. In 2021 the company made an earnings per share (EPS) of $0.67 an increase over its 2020 EPS that were of $0.57.
EPS history for Global Cord Blood from 2009 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | $0.64 | -3.64% |
| 2021 | $0.67 | 16.46% |
| 2020 | $0.57 | 4.2% |
| 2019 | $0.55 | 90.81% |
| 2018 | $0.29 | -15.48% |
| 2017 | $0.34 | 74.76% |
| 2016 | $0.19 | -4.62% |
| 2015 | $0.20 | -20.49% |
| 2014 | $0.26 | 7.74% |
| 2013 | $0.24 | |
| 2009 | $0.01148 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 RadNet RDNT | -$0.23 | -135.81% | 🇺🇸 USA |
 National Healthcare
NHC | $2.07 | 222.32% | 🇺🇸 USA |
 NeoGenomics
NEO | -$0.92 | -243.26% | 🇺🇸 USA |
 Cryo-Cell CCEL | $0.30 | -53.29% | 🇺🇸 USA |